Literature DB >> 7107006

Immunochemical identification of viral and nonviral proteins of the respiratory syncytial virus virion.

B F Fernie, J L Gerin.   

Abstract

We identified by immunochemical methods 13 polypeptides associated with the infectious respiratory syncytial virus virion. Eight of these polypeptides (VP200, VP84, VP66, VP43, VP40, VP37, VP28, and VP19) were identified as virus specific. Two other polypeptides, (VP) 22 and (VP) 12, are provisionally considered to be of viral origin. Three nonviral proteins are also intimately associated with the infectious virion. These nonviral proteins were identified as cellular actin and two proteins with bovine serum albumin immunospecificity. VP40 was identified as the major ribonucleoprotein. Based on biochemical and biophysical similarities with paramyxovirus proteins, other respiratory syncytial virus proteins are believed to have these specific viral functions: VP84, "hemagglutinin"; VP66, undissociated fusion protein, F1,2; VP43, F1; and VP19, F2, VP66 contains a major determinant involved in viral infectivity since all neutralizing antibodies tested, including a monoclone, precipitated this protein.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7107006      PMCID: PMC347519          DOI: 10.1128/iai.37.1.243-249.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Respiratory syncytial virus proteins.

Authors:  W H Wunner; C R Pringle
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

2.  Effect of detergents on antibody-antigen interaction.

Authors:  G J Dimitriadis
Journal:  Anal Biochem       Date:  1979-10-01       Impact factor: 3.365

3.  Structural polypeptides of mumps virus.

Authors:  C Orvell
Journal:  J Gen Virol       Date:  1978-12       Impact factor: 3.891

4.  Human erythrocyte membrane glycoprotein: a re-evaluation of the molecular weight as determined by SDS polyacrylamide gel electrophoresis.

Authors:  J P Segrest; R L Jackson; E P Andrews; V T Marchesi
Journal:  Biochem Biophys Res Commun       Date:  1971-07-16       Impact factor: 3.575

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Properties of an oncornavirus glycoprotein: evidence for its presence on the surface of virions and infected cells.

Authors:  S J Kennel; B C Del Villano; R L Levy; R A Lerner
Journal:  Virology       Date:  1973-10       Impact factor: 3.616

7.  The polypeptides of canine distemper virus: synthesis in infected cells and relatedness to the polypeptides of other morbilliviruses.

Authors:  W W Hall; R A Lamb; P W Choppin
Journal:  Virology       Date:  1980-01-30       Impact factor: 3.616

8.  Monoclonal antibodies to respiratory syncytial virus: detection of virus neutralization and other antigen-antibody systems using infected human and murine cells.

Authors:  P J Cote; B F Fernie; E C Ford; J W Shih; J L Gerin
Journal:  J Virol Methods       Date:  1981-10       Impact factor: 2.014

9.  Effect of interferon on mouse leukaemia virus (MuLV). V. Abnormal proteins in virions of Rauscher MuLV produced in the presence of interferon.

Authors:  P M Pitha; B Fernie; F Maldarelli; T Hattman; N A Wivel
Journal:  J Gen Virol       Date:  1980-01       Impact factor: 3.891

10.  Actin is the naturally occurring inhibitor of deoxyribonuclease I.

Authors:  E Lazarides; U Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

View more
  40 in total

1.  Transcription of human respiratory syncytial virus genome RNA in vitro: requirement of cellular factor(s).

Authors:  S Barik
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  Comparison of caprine, human and bovine strains of respiratory syncytial virus.

Authors:  M Trudel; F Nadon; C Simard; F Bélanger; R Alain; C Séguin; G Lussier
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  Identification of epitopes on respiratory syncytial virus proteins by competitive binding immunoassay.

Authors:  L J Anderson; J C Hierholzer; Y O Stone; C Tsou; B F Fernie
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

Review 4.  Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

Authors:  V G Hemming; G A Prince; J R Groothuis; G R Siber
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

Review 5.  Molecular mechanisms driving respiratory syncytial virus assembly.

Authors:  Fyza Y Shaikh; James E Crowe
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

6.  Construction and characterization of cDNA clones for four respiratory syncytial viral genes.

Authors:  S Venkatesan; N Elango; R M Chanock
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

7.  Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity.

Authors:  R A Olmsted; N Elango; G A Prince; B R Murphy; P R Johnson; B Moss; R M Chanock; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

8.  Antibody response to respiratory syncytial virus structural proteins in children with acute respiratory syncytial virus infection.

Authors:  R Vainionpää; O Meurman; H Sarkkinen
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

9.  Proteomic analysis of purified coronavirus infectious bronchitis virus particles.

Authors:  Qingming Kong; Chunyi Xue; Xiangpeng Ren; Chengwen Zhang; Linlin Li; Dingming Shu; Yingzuo Bi; Yongchang Cao
Journal:  Proteome Sci       Date:  2010-06-09       Impact factor: 2.480

10.  Site-directed serology with synthetic peptides representing the large glycoprotein G of respiratory syncytial virus.

Authors:  E Norrby; M A Mufson; H Alexander; R A Houghten; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.